Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Verastem, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
OHSU Knight Cancer Institute
Nektar Therapeutics
AstraZeneca
Royal Marsden NHS Foundation Trust